Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Minipigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Minipigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

Cellect Is Moving To Trade Exclusively On The

  • Post author:Sam
  • Post published:June 8, 2017
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingCellect Is Moving To Trade Exclusively On The

Caris Life Sciences' Molecular Intelligence Platform Identifies Patients With MSI-High (Or Mismatch Repair Deficient) Solid Tumors More Likely To Respond To Immunotherapy

  • Post author:Sam
  • Post published:June 8, 2017
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingCaris Life Sciences' Molecular Intelligence Platform Identifies Patients With MSI-High (Or Mismatch Repair Deficient) Solid Tumors More Likely To Respond To Immunotherapy

<b>Saama</b> Announces Innovative Clinical Data Management As A Service (CDaaS) Solution

  • Post author:Sam
  • Post published:June 8, 2017
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue Reading<b>Saama</b> Announces Innovative Clinical Data Management As A Service (CDaaS) Solution

<b>Blue Ribbon</b> Highlights Session Recognizes Best Posters From 21st <b>International Congress Of Parkinson???s Disease And Movement Disorders</b>

  • Post author:Sam
  • Post published:June 8, 2017
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue Reading<b>Blue Ribbon</b> Highlights Session Recognizes Best Posters From 21st <b>International Congress Of Parkinson???s Disease And Movement Disorders</b>

Intuitive Surgical Reports New Employee Option Grants For June 2017

  • Post author:Sam
  • Post published:June 8, 2017
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingIntuitive Surgical Reports New Employee Option Grants For June 2017

KPH Healthcare Adds Three Companies to Generics Drug Price-Fixing Lawsuits

  • Post author:Sam
  • Post published:June 8, 2017
  • Post category:Drug Industry Daily

A pharmacy chain operator that brought antitrust class action lawsuits against more than a dozen generics manufacturers earlier this week has added three more — Actavis Holdco, Lannett and Epic…

Continue ReadingKPH Healthcare Adds Three Companies to Generics Drug Price-Fixing Lawsuits

ABPI Reprimands Astellas UK and Gedeon Richter for Publishing Inaccurate Information

  • Post author:Sam
  • Post published:June 8, 2017
  • Post category:Drug Industry Daily

The Association of the British Pharmaceutical Industry will run advertisements later this month in three medical journals listing Astellas UK and Gedeon Richter as in breach of the ABPI’s Code…

Continue ReadingABPI Reprimands Astellas UK and Gedeon Richter for Publishing Inaccurate Information

FDA Planning Phased Transition to New Cures Act Drug Development Tool Qualification Scheme

  • Post author:Sam
  • Post published:June 8, 2017
  • Post category:Drug Industry Daily

The FDA is planning to transition to a new drug development tool qualification process — as required by the 21st Century Cures Act — for clearing the use of biomarkers,…

Continue ReadingFDA Planning Phased Transition to New Cures Act Drug Development Tool Qualification Scheme

FDA Requests Endo Remove Opioid Painkiller Opana ER From the Market After Reports of Abuse

  • Post author:Sam
  • Post published:June 8, 2017
  • Post category:Drug Industry Daily

The FDA requested that Endo Pharmaceuticals voluntarily remove its opioid painkiller Opana ER from the market, saying its benefits may no longer outweigh its risks of abuse — the first…

Continue ReadingFDA Requests Endo Remove Opioid Painkiller Opana ER From the Market After Reports of Abuse

Medical Device Single Audit Program Gains Momentum

  • Post author:Sam
  • Post published:June 8, 2017
  • Post category:The GMP Letter

Companies most likely to benefit from the Medical Device Single Audit Program will include those selling products in Canada, along with manufacturers of finished medical devices and high-risk devices, said…

Continue ReadingMedical Device Single Audit Program Gains Momentum
  • Go to the previous page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 33
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:
6042 Cornerstone Court W
Suite E
San Diego, CA 92121
Social::
© 2025 BioLegacy Research. All rights reserved.
BioLegacy research is a PharmaLegacy Laboratories company